Previous 10 | Next 10 |
home / stock / hbp:cc / hbp:cc news
SQI Diagnostics Inc. (SQD.H:CA) is expected to report for quarter end 2023-12-31 Petrus Resources Ltd. (PRQ:CA) is expected to report $0.02 for Q4 2023 Pedro Resources Ltd (VBN:CNX) is expected to report for quarter end 2023-12-31 Americas Gold and Silver Corporation (USA:CA) is expec...
(TheNewswire) January 18, 2024 – TheNewswire - Toronto, Ontario – Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its pr...
(TheNewswire) Toronto, Ontario – TheNewswire – December 14, 2023 – Helix BioPharma Corp. (TSX:HBP), (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in ...
VersaBank (VBNK:CA) is expected to report $0.44 for Q4 2023 Genesis Land Development Corp. (GDC:CA) is expected to report for Q2 2024 Aberdeen International Inc. (AAB:CA) is expected to report for Q1 2024 Crown Capital Partners Inc. (CRWN:CA) is expected to report for Q1 2024 Diam...
Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024
(TheNewswire) Toronto, Ontario - TheNewswire - October 27, 2023 - Helix BioPharma Corp. (TSX:HBP) , (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immu...
(TheNewswire) Toronto, Ontario - TheNewswire - October 10, 2023 - Helix BioPharma Corp. (TSX:HBP) (“ Helix ” or the “ Company ”), an immune-oncology antibody-drug-conjugate company developing an innovative drug platform for the...
(TheNewswire) Toronto, Ontario - TheNewswire - August 22, 2023 - Helix BioPharma Corp. (TSX:HBP) (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology...
(TheNewswire) Toronto, Ontario – TheNewswire – June 14, 2023 - Helix BioPharma Corp. (TSX:HBP), (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in the field of im...
(TheNewswire) Toronto, O N - TheNewswire - March 15, 2023 - Helix BioPharma Corp. (TSX:HBP) , (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in the field of im...
News, Short Squeeze, Breakout and More Instantly...
Helix BioPharma Corp. Company Name:
HBP:CC Stock Symbol:
TSXC Market:
Crown Capital Partners Inc. (CRWN:CA) is expected to report for Q1 2024 Aberdeen International Inc. (AAB:CA) is expected to report for Q1 2025 Haivision Systems Inc. (HAI:CA) is expected to report for Q2 2024 Peyto Exploration & Development Corp. (PEY:CA) is expected to report $0....
Batero Gold Corp. (BAT:CA) is expected to report for Q2 2024 Barrick Gold Corporation (ABX:CA) is expected to report $0.22 for Q1 2024 Exco Technologies Limited (XTC:CA) is expected to report $0.17 for Q2 2024 Amerigo Resources Ltd. (ARG:CA) is expected to report for Q1 2024 Parkl...
Wall Financial Corporation (WFC:CA) is expected to report for quarter end 2024-01-31 Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024 Choice Properties Real Estate Investment Trust (CHP.UN:CA) is expected to report $0.26 for Q1 2024 Celestica Inc. Subordinate Voting Sh...